Publications by authors named "Gary Leiserowitz"

Claim this Profile
I
Integration of label-free surface enhanced Raman spectroscopy (SERS) of extracellular vesicles (EVs) with Raman tagged labels to enhance ovarian cancer diagnostics.
Qing He, Hanna J Koster, Justin O'Sullivan, Samantha G Ono, Hannah J O'Toole, Gary S Leiserowitz

Biosens Bioelectron· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Attitudes Toward Ambient Voice Technology: Preimplementation Patient Survey in an Academic Medical Center.
Gary Leiserowitz, Jeff Mansfield, Scott MacDonald, Melissa Jost

JMIR Med Inform· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy.
Brice E N Wamba, Tanmoy Mondal, Francis Freenor V, Mehr Shaheed, Oliver Pang, Gary Scott Leiserowitz

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham, Gary Leiserowitz

J Natl Compr Canc Netw· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Documentation of Infertility Risk Discussion in Cancer Patients Receiving Cancer-Directed Therapy: The UC Davis Cancer Center Experience.
Colleen McCann, Natalie Kamiyama, Debra Burgess, Angela E Usher, Jeffrey Fine, Gary S Leiserowitz

J Adolesc Young Adult Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives of gynecologic oncology fellowship training and preparedness for practice.
Nancy T Nguyen, Allyson M Jang, Tali Pomerantz, Gerald S Zavorsky, Gary Leiserowitz

Gynecol Oncol Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers.
Nancy T Nguyen, Alan Raetz, Dennis Montoya, Vincent Schilling, Caili Tong, Gary Leiserowitz

Gynecol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.
Tanmoy Mondal, Himanshu Gaur, Brice E N Wamba, Abby Grace Michalak, Camryn Stout, Gary Scott Leiserowitz

Cell Death Differ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to completion of radiation treatment in locally advanced squamous cell carcinoma of the vulva and the impact on survival.
Nancy T Nguyen, Xiao Zhao, Matthew Ponzini, Machelle Wilson, Gary Leiserowitz

Gynecol Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, Jamie N Bakkum-Gamez, Lisa Barroilhet, Gary Leiserowitz

J Natl Compr Canc Netw· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Components of Protein Homeostasis Pathway Can Be Targeted to Produce Drug Synergies with VCP Inhibitors in Ovarian Cancer.
Prabhakar Bastola, Gary S Leiserowitz, Jeremy Chien

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetraspanins are unevenly distributed across single extracellular vesicles and bias sensitivity to multiplexed cancer biomarkers.
Rachel R Mizenko, Terza Brostoff, Tatu Rojalin, Hanna J Koster, Hila S Swindell, Gary S Leiserowitz

J Nanobiotechnology· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma.
Hui Chen, Kristin Gotimer, Cristabelle De Souza, Clifford G Tepper, Anthony N Karnezis, Gary S Leiserowitz

Gynecol Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer.
Suzanne Miyamoto, Carol D Stroble, Sandra Taylor, Qiuting Hong, Carlito B Lebrilla, Gary S Leiserowitz

J Proteome Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible.
Eugenia Girda, Eric C Huang, Gary S Leiserowitz, Lloyd H Smith

Int J Gynecol Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy.
Alison A Nielsen, Tehani A Liyanage, Gary S Leiserowitz, Jyoti Mayadev

J Contemp Brachytherapy· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study.
Gary S Leiserowitz, Jeff F Lin, Ana I Tergas, William A Cliby, Robert E Bristow

Int J Gynecol Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multispectral Optical Tweezers for Biochemical Fingerprinting of CD9-Positive Exosome Subpopulations.
Randy P Carney, Sidhartha Hazari, Macalistair Colquhoun, Di Tran, Billanna Hwang, Gary S Leiserowitz

Anal Chem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.
Suzanne Miyamoto, L Renee Ruhaak, Carol Stroble, Michelle R Salemi, Brett Phinney, Gary S Leiserowitz

J Proteome Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study.
Sumer K Wallace, Jeff F Lin, William A Cliby, Gary S Leiserowitz, Ana I Tergas

J Natl Compr Canc Netw· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.
L Renee Ruhaak, Kyoungmi Kim, Carol Stroble, Sandra L Taylor, Qiuting Hong, Gary Leiserowitz

J Proteome Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer.
Rosemary D Cress, Yingjia S Chen, Cyllene R Morris, Megan Petersen, Gary S Leiserowitz

Obstet Gynecol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preserving sexual function in women and girls with cancer: survivorship is about more than just surviving.
Vanessa A Kennedy, Gary S Leiserowitz

Am J Obstet Gynecol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer.
Adam Huddleston, Sally Zhen, Lihong Qi, Dominique Rash, Gary Leiserowitz

J Contemp Brachytherapy· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis